Dysautonomia Intl. on X: Vanderbilt researchers recently presented new data on the use of guanfacine in 47 hyperadrenergic #POTS patients. They note that 72% of patients responded well to the medication. Read

$ 11.50

4.5
(670)
In stock
Description

Dysautonomia Intl. on X: The largest study on #POTS and pregnancy to date, a collaboration between Dysautonomia International, Vanderbilt University, and University of Calgary, has published! Key findings from an analysis of

Frontiers Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies

Dysautonomia Intl. (@Dysautonomia) / X

Dysautonomia International

Frontiers Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies

Health Advocate 🇨🇦 (@Angelaresetar) / X

QOP3 49 DEJONG Nathan White Matter Network Structure as a Substrate of Cognitive Reserve

Long-COVID postural tachycardia syndrome: an American Autonomic Society statement

Frontiers YangXue QingNao Wan, a Compound Chinese Medicine, Attenuates Cerebrovascular Hyperpermeability and Neuron Injury in Spontaneously Hypertensive Rat: Effect and Mechanism